ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS

摘要:

Prospects for a more successful photodynamic therapy for cancer are increasing as early trials with benzoporphyrin derivative [BPD] produce encouraging results. This new drug has several advantages over the existing product, Photofrin®. But the therapeutic goals for BPD do not stop there. Researchers from Quadra Logic Technologies hope to develop a whole new mode of therapy for systemic diseases based on its properties. At the IBC conference, Drug Delivery and Targeting Systems, in London, UK, delegates were told of this latest development.

ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS

摘要:

Recently, the governments of Australia and Ontario, Canada, introduced legislation requiring the submission of economic data before a new medicine is considered for reimbursement. As more and more governments follow this lead and identify drug expenditure as a convenient target for cost-containment, the pharmaceutical industry must take stock and consider how these changes will affect its business. This was one of the issues debated at the 3rd Major Pharmaceutical Forum on Strategic Developments in Health Economics organised by IIR Ltd and held in London, UK, in December 1993.

ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1994

数据来源: ADIS